You searched for "patient"
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy
Neutrophil-to-lymphocyte ratio has been shown to be a prognostic factor in a number of different cancers. This is one of the largest studies to date to evaluate its effect on overall survival in patients who have undergone radical prostatectomy (RP)...
Renal fossa recurrence after nephrectomy for renal cell carcinoma
This paper is an analysis of 36 years of radical nephrectomy for renal cell carcinoma in the Mayo Clinic (1970-2006). In particular, it contains an analysis of the risk of renal fossa recurrence after nephrectomy (partial nephrectomies are not included)...The Royal Marsden: Fundamentals of Bladder Cancer for Nurses and AHPs
Introducing the fundamentals of bladder cancer; including signs and symptoms, diagnosis, types of disease and management. The day will feature the role of the nurse at different stages of the pathway. We have expert clinical speakers to deliver the session along with sessions run by our expert patients.The Royal Marsden: Uro-Oncology Study Day
Introducing the fundamentals of bladder cancer; including signs and symptoms, diagnosis, types of disease and management. The day will feature the role of the nurse at different stages of the pathway. We have expert clinical speakers to deliver the session...The 10 commandments of laparoscopic urology
Laparoscopic urologic procedures continue to attract the interest of trainees, consultants and the public, and the demand for training is on the increase [1,2,3]. The vast majority of laparoscopic procedures are laparoscopic nephrectomies and this is certainly the most common...TUF Innovation and Research Fund
Since The Urology Foundation (TUF) was founded 26 years ago the charity has been at the heart of the step change in the treatment and care for urology patients. Building on past achievements, TUF are continuing to develop programmes and...Movember launches world’s largest cancer real world evidence network
Movember has launched the world’s largest prostate cancer and testicular clinical and research network, aimed at improving the overall survival and quality of life for those living with diseases that affect over 1.4 million men worldwide every year. The leading...Read all about it Jul/Aug 2015
It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking about! So this section...TUF Warriors – joining the fundraising fight
What is the TUF Warrior programme? The Urology Foundation (TUF) Warrior programme is designed to support core trainees, clinical fellows and foundation doctors interested in urology. It creates opportunities to develop extracurricular interests, connect with patients, boost applications for specialty...Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in...Bladder cancer diagnosis and follow up: A new proven urinary biomarker to support the post COVID-19 recovery phase
Since lockdown began most urologists have been following the advice of BAUS Oncology, to minimise the risk of exposure of patients and staff to potential COVID-19 infection: the result is an increasing backlog of patients requiring tests to determine if...
